Innovation Night

Innovation Night 2021 at La Jolla Playhouse

» View the Digital Program here!

Thank you for making Innovation Night 2021 a success!

As a leader in innovation on stage, La Jolla Playhouse couldn’t be a better organization to host this extraordinary event each year, bringing San Diego’s flourishing community of science and technology innovators together for an evening of creative exchange. Over the last 14 years, funds raised at Innovation Night have enhanced the Playhouse’s own “R&D” efforts – including our signature play development programs, Without Walls (WOW) series of immersive and site-based theatre, as well as ongoing artist commissions and residencies – all while facilitating partnerships among artists and leaders in San Diego’s life sciences, biotech, high-tech, clean-tech and telecommunication industries.


Monday, September 27, 2021
5:30 pm – 8:30 pm
at La Jolla Playhouse

David Hale - 2021 Innovation Night Honoree
David F. Hale
Chairman & CEO, Hale BioPharma Ventures, LLC

About David F. Hale

David F. Hale is Chairman and CEO of Hale BioPharma Ventures, LLC a private company focused on the formation and development of biotechnology, specialty pharma, diagnostic and medical device companies. Mr. Hale is a serial entrepreneur who has been involved in the formation and development of a number of successful biomedical companies. He served as Chairman of Santarus, Inc., prior to its sale to Salix Pharmaceuticals, Inc. in 2014, SkinMedica, Inc., prior to its sale to Allergan in 2012, Micromet, Inc., prior to its sale to Amgen Inc. in 2012, Somaxon Pharmaceuticals, prior to its sale to Pernix in 2013, Crisi Medical Systems, prior to its sale to Becton-Dickinson in 2015, and Agility Clinical, prior to its sale to Precision Medicine in 2017. In 1982, after joining Hybritech, Inc., the first biotechnology company in San Diego, he served as COO, President and then CEO, when Hybritech was acquired by Eli Lilly and Co. in 1986. From 1987 to 1997, he was Chairman, President and CEO of Gensia, Inc., which merged with SICOR to become Gensia Sicor, Inc., which was acquired by Teva Pharmaceuticals. He was a co-founder and Chairman of Viagene, Inc. from 1987 to 1995, when Viagene was acquired by Chiron, Inc. In 1997, he was a co-founder and served as Chairman of LMA North America until its merger with LMA International in 2004. He joined CancerVax in October 2000, where he served as President and CEO from 2000 until its merger with Micromet, Inc, in 2006, when he became Chairman. He currently serves on the board of two public companies, Oncternal Therapeutics, Inc., as Chairman, and BIOCEPT, Inc. He also serves on the Board of Directors of private companies Zerigo Health, Inc., Recros Medica, Inc., and Adigica Health, Inc. He is a co-founder and Chairman of Neurana Pharmaceuticals, Inc., a co-founder and Director of Neurelis, Inc., a co-founder and Managing Member of Dermata Therapeutics, Inc., and a co-founder of Cadence, Evoke, Elevation and Zogenix. Prior to joining Hybritech, Hale was Vice President and General Manager of BBL Microbiology Systems, a division of Becton, Dickinson & Co. and from 1971 to 1980, held various marketing and sales management positions with Ortho Pharmaceutical Corporation, a division of Johnson & Johnson, Inc. Mr. Hale is a co-founder and serves on the Board of Directors of BIOCOM and CONNECT and is a former member of the Board of the Biotechnology Industry Organization (BIO), and the Biotechnology Institute. He has served on the Board of Rady Children’s Hospital since 1986, including Chairman of the Board from 2011 to 2015, and is founder and Chairman of the Rady Children’s Institute of Genomic Medicine. He serves on the University of San Diego Board of Trustees, is a member of the UCSD Rady School of Management Dean’s Advisory Council, and a Director of the San Diego Economic Development Corporation.

Gallery Hosts: Axiom Space, Biocept, DTx Pharma, Illumina, IQHQ, Nanome, Neurelis, Oncternal Therapuetics, Origami Air, Qualcomm, Rady Children’s Hospital Foundation, Stockdale Capital Partners LLC, UC San Diego, UC San Diego Office of Innovation and Commercialization

If you were unable to attend, please consider supporting innovation at the Playhouse by clicking here:

Event Sponsors

Thank you to our generous sponsors who have committed to support La Jolla Playhouse:

Lead Sponsors

BioMed Realty UC San Diego

Host Sponsors

Cooley The Lodge at Torrey Pines Qualcomm
Rady Children's Hospital Stockdale Capital Partners

Co-Host Sponsors

Aspen Neuroscience Biocept Carson Royston Group
Domain Associates Dowling & Yahnke DTx Pharma
Hale BioPharma Ventures, LLC Histogen Illumina
Ionis Pharmaceuticals IQHQ KindredBio
La Jolla Institute for Immunology Locanabio Luna DNA
Marsh & McLennan Agency Neurelis Oncternal Therapeutics
ResMed logo San Diego State University TEGA Therapeutics

In-Kind Sponsors

Biocom California logo Bright Event Rentals Doug Gifford Photography
Floral FX La Cuisine Custom Catering PRP WINE INTERNATIONAL
Show Imaging, Inc. Snake Oil Cocktail Co.


Innovation Night Host Committee

Chair: Tim Scott, CEO, TEGA Therapeutics
Gordon Alton, CEO and President, Agragene Inc.
Denise Bevers, COO, DTx Pharma
Charles Black, Managing Director, J.P. Morgan Private Bank
Jim Breitmeyer, M.D., Ph.D., President and CEO, Oncternal Therapeutics Inc.
Carin Canale-Theakston, Chief Executive Officer, CanaleComm
Jennifer Cayer, Chief Business Officer, Pulmocide Limited
Edward Dennis, Ph.D., Departments of Chemistry & Biochemistry and Pharmacology, UC San Diego
Anna E. Diaz, Principal, Lead Advisor, Dowling & Yahnke Wealth Advisors
Leo Divinsky, Managing Director of Asset Management, Stockdale Capital Partners, LLC
Brian Dovey, Partner, Domain Associates
Susan Dubé, Founder and CFO of Sorriso Pharmaceuticals, Inc.
John Dunn, General Counsel and Corporate Secretary, Vital Therapies Inc.
Stephen C. Ferruolo, Partner, Perkins Coie LLP
Patrick Frias, M.D., President & Chief Executive Officer Rady Children’s Hospital and Health Center-San Diego
Jeff Friedman, Managing Partner, Friedman Bioventure
Wendy Gillespie, CEO, Starhawk Productions
Gerardo Godinez, Partner in Charge, Moss Adams
Clark Guy, Managing Director, Market Executive, Bank of America Private Bank
Susie Harborth, EVP Business Operations Breakthrough Properties, Mission BioCapital
Greg Horowitt, Co-Founder & Managing Director, T2 Venture Capital
Vyomesh Joshi, CEO & President, 3D Systems
Bob Kain, Co-Founder and Chairman, Luna DNA
Bryan Knox, General Manager, Catalent
Mike Krenn, CEO, Connect
James MacKay, CEO, Aristea Therapeutics
Stanley Maloy, Associate Vice President for Research & Innovation, San Diego State University
Magda Marquet, Founder and Co-Chair, Althea
Chris Montgomery, SVP, Business Development, Cooley
Julie Stone Moran, San Diego Office Marketplace Leader, Deloitte
Tom Murphy, Senior Vice President, Bench International
Mike Nall, President and CEO, Biocept
Joe Panetta, CEO & President, Biocom
Bernard Parker, Managing Director, Caligen Bio
Richard W. Pascoe, President and CEO, Histogen, Inc
Robert Price, Managing Director, TI Management
Christopher A. and Sharon Lee Rhodes, Baywind Bioventures
Don Rosenberg, Executive Vice President, General Counsel and Corporate Strategy, Qualcomm
Ivor Royston, President and CEO, Viracta
Drew Senyei, Managing Director, Enterprise Partners Venture Capital
Natalie Sherod, Risk Advisor, Cavignac
Larry Stambaugh, Principal, Apercu Partners
Andy Thomas, Senior Vice President Business Development, Evans Hotels
Kelly Thomson, Regional Managing Director, Ascent Private Capital Management of U.S. Bank
Mary Walshok, Associate Vice Chancellor for Public Programs, UC San Diego
David R. Webb, Chairman of the Board, Agragene
Lorelei Westin, Member, Wilson Sonsini Goodrich & Rosati

2022 April
2022 May
2022 June
Sunday Monday Tuesday Wednesday Thursday Friday Saturday
  • No Shows this month
Join Us!

Sign up to our email list and be the first to know about show announcements, ticket on-sales and special events.

By providing your cell, you agree to automated text messages for show reminders and occasional announcements. Rates may apply.